Aptar Pharma Gains Approval by European Medicines Agency for Electronic Lockout Device

Aptar Pharma has announced approval by the European Medicines Agency (EMA) for integrated electronic nasal lockout device e-Lockout following a multi-year development with Takeda Pharmaceuticals International.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news